Imagen de Portada

Cardiovascular disease in the antiphospholipid syndrome

The prevalence of cardiovascular disease (CVD) in antiphospholipid syndrome (APS) varies from one series to another depending on the definition of CVD and tools used for its detection. Atherosclerosis, the usual cause of CVD, starts when the endothelium becomes damaged and is considered to be an aut...

Descripción completa

Detalles Bibliográficos
Autores Principales: Amaya-Amaya, Jenny, Rojas-Villarraga, Adriana, Anaya, Juan-Manuel
Formato: Objeto de conferencia (Conference Object)
Lenguaje:Inglés (English)
Publicado: SAGE Publications Ltd 2014
Materias:
High density lipoprotein
Lupus anticoagulant
Beta2 glycoprotein 1
Anticoagulant therapy
Antiphospholipid syndrome
Blood vessel injury
Cardiovascular disease
Cardiovascular risk
Conference paper
Congestive cardiomyopathy
Early diagnosis
Follow up
Heart infarction
Human
Hypertriglyceridemia
Lifestyle modification
Lung embolism
Prevalence
Pulmonary hypertension
Thrombotic thrombocytopenic purpura
Cardiovascular diseases
Complication
Physiology
Risk factor
Beta 2-glycoprotein i
Humans
Risk factors
Novel risk factors
Traditional risk factors
Acceso en línea:https://repository.urosario.edu.co/handle/10336/22542
https://doi.org/10.1177/0961203314540015

Internet

https://repository.urosario.edu.co/handle/10336/22542
https://doi.org/10.1177/0961203314540015

Ejemplares similares